162 related articles for article (PubMed ID: 31470801)
1. Expression of thioredoxin 1 and peroxiredoxins in squamous cervical carcinoma and its predictive role in NACT.
Zhu H; Tao X; Zhou L; Sheng B; Zhu X; Zhu X
BMC Cancer; 2019 Aug; 19(1):865. PubMed ID: 31470801
[TBL] [Abstract][Full Text] [Related]
2. Predictive role of galectin-1 and integrin α5β1 in cisplatin-based neoadjuvant chemotherapy of bulky squamous cervical cancer.
Zhu H; Chen A; Li S; Tao X; Sheng B; Chetry M; Zhu X
Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28842515
[TBL] [Abstract][Full Text] [Related]
3. Proteomic identification of neoadjuvant chemotherapy-related proteins in bulky stage IB-IIA squamous cervical cancer.
Zou S; Shen Q; Hua Y; Jiang W; Zhang W; Zhu X
Reprod Sci; 2013 Nov; 20(11):1356-64. PubMed ID: 23599374
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy.
Choi CH; Song SY; Choi JJ; Park YA; Kang H; Kim TJ; Lee JW; Kim BG; Lee JH; Bae DS
BMC Cancer; 2008 Oct; 8():295. PubMed ID: 18847499
[TBL] [Abstract][Full Text] [Related]
5. Outcome of patients with bulky IB (≥ 6 cm) cervical squamous cell carcinoma with and without cisplatin-based neoadjuvant chemotherapy.
Wang PH; Chang YH; Yang YH; Chang WH; Huang SY; Lai CR; Juang CM; Chen YJ; Horng HC; Wen KC; Ng HT; Yuan CC; Chao KC; Yen MS
Taiwan J Obstet Gynecol; 2014 Sep; 53(3):330-6. PubMed ID: 25286786
[TBL] [Abstract][Full Text] [Related]
6. Detection of cell apoptosis in pelvic lymph nodes of patients with cervical cancer after neoadjuvant chemotherapy.
Zhang H; Peng W; Zhang Y
J Int Med Res; 2014 Jun; 42(3):641-50. PubMed ID: 24651993
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of Annexin A2 and S100A proteins in patients with bulky stage IB-IIA cervical cancer treated with neoadjuvant chemotherapy.
Jin L; Shen Q; Ding S; Jiang W; Jiang L; Zhu X
Gynecol Oncol; 2012 Jul; 126(1):140-6. PubMed ID: 22487537
[TBL] [Abstract][Full Text] [Related]
8. Identification of cervical cancer proteins associated with treatment with paclitaxel and cisplatin in patients.
Liu H; Han Y; Mi R; Zhang Y; Su G; Wang H; Zhou X; Liu X; Zhu B
Int J Gynecol Cancer; 2011 Nov; 21(8):1452-7. PubMed ID: 22027750
[TBL] [Abstract][Full Text] [Related]
9. Proteomic identification of predictive tissue biomarkers of sensitive to neoadjuvant chemotherapy in squamous cervical cancer.
Guo L; Zhang C; Zhu J; Yang Y; Lan J; Su G; Xie X
Life Sci; 2016 Apr; 151():102-108. PubMed ID: 26947588
[TBL] [Abstract][Full Text] [Related]
10. Expression of p53 and apoptosis of tumor cells in locally advanced cervical carcinoma after cisplatin based neoadjuvant chemotherapy.
Garzetti GG; Ciavattini A; Provinciali M; Di Stefano G; Lucarini G; Goteri G; Biagini G
Anticancer Res; 1996; 16(5B):3229-34. PubMed ID: 8920796
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of phosphorylated histone H2AX expressions in the cervical cancer patients of pre- and post-neoadjuvant chemotherapy.
Zhao J; Wang Q; Li J; Si TB; Pei SY; Guo Z; Jiang C
Eur J Gynaecol Oncol; 2015; 36(3):318-22. PubMed ID: 26189260
[TBL] [Abstract][Full Text] [Related]
12. PKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer.
Zhu H; Wu J; Zhang W; Luo H; Shen Z; Cheng H; Zhu X
Sci Rep; 2016 Aug; 6():30788. PubMed ID: 27492148
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy for advanced stage cervical cancer in a pregnant patient: report of one case with rapid tumor progression.
Benhaim Y; Pautier P; Bensaid C; Lhommé C; Haie-Meder C; Morice P
Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):267-8. PubMed ID: 17157432
[No Abstract] [Full Text] [Related]
14. Tumor-infiltrating CD8+ and FOXP3+ lymphocytes before and after neoadjuvant chemotherapy in cervical cancer.
Liang Y; Lü W; Zhang X; Lü B
Diagn Pathol; 2018 Nov; 13(1):93. PubMed ID: 30474571
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of pathological response to neoadjuvant chemotherapy in bulky stage Ib2 and IIa cervical squamous cell cancer patients.
Liang Y; Lü B; Chen X; Qin J; Cheng X; Xie X; Lü W
Virchows Arch; 2016 Mar; 468(3):329-36. PubMed ID: 26637198
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant paclitaxel and cisplatin in uterine cervical cancer: long-term results.
Park DC; Suh MJ; Yeo SG
Int J Gynecol Cancer; 2009 Jul; 19(5):943-7. PubMed ID: 19574789
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of p-STAT3 in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy.
Choi CH; Song SY; Kang H; Lee YY; Kim CJ; Lee JW; Kim TJ; Kim BG; Lee JH; Bae DS
J Obstet Gynaecol Res; 2010 Apr; 36(2):304-10. PubMed ID: 20492381
[TBL] [Abstract][Full Text] [Related]
18. Expression of thioredoxin system and related peroxiredoxin proteins is associated with clinical outcome in radiotherapy treated early stage breast cancer.
Woolston CM; Storr SJ; Ellis IO; Morgan DA; Martin SG
Radiother Oncol; 2011 Aug; 100(2):308-13. PubMed ID: 21641069
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
[No Abstract] [Full Text] [Related]
[Next] [New Search]
